List of Tables
Table 1. Global Ropivacaine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Ropivacaine Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Ropivacaine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Ropivacaine Sales (K Doses) of Key Manufacturers (2020-2025)
Table 5. Global Ropivacaine Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Ropivacaine Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Ropivacaine Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Ropivacaine Average Price (US$/Dose) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Ropivacaine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Ropivacaine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Ropivacaine, Product Type & Application
Table 12. Global Key Manufacturers of Ropivacaine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Ropivacaine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ropivacaine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Ropivacaine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Ropivacaine Sales by Region (2020-2025) & (K Doses)
Table 18. Global Ropivacaine Sales Market Share by Region (2020-2025)
Table 19. Global Ropivacaine Sales by Region (2026-2031) & (K Doses)
Table 20. Global Ropivacaine Sales Market Share by Region (2026-2031)
Table 21. Global Ropivacaine Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Ropivacaine Revenue Market Share by Region (2020-2025)
Table 23. Global Ropivacaine Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Ropivacaine Revenue Market Share by Region (2026-2031)
Table 25. North America Ropivacaine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Ropivacaine Sales by Country (2020-2025) & (K Doses)
Table 27. North America Ropivacaine Sales by Country (2026-2031) & (K Doses)
Table 28. North America Ropivacaine Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Ropivacaine Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Ropivacaine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Ropivacaine Sales by Country (2020-2025) & (K Doses)
Table 32. Europe Ropivacaine Sales by Country (2026-2031) & (K Doses)
Table 33. Europe Ropivacaine Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Ropivacaine Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Ropivacaine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Ropivacaine Sales by Region (2020-2025) & (K Doses)
Table 37. Asia Pacific Ropivacaine Sales by Region (2026-2031) & (K Doses)
Table 38. Asia Pacific Ropivacaine Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Ropivacaine Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Ropivacaine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Ropivacaine Sales by Country (2020-2025) & (K Doses)
Table 42. Latin America Ropivacaine Sales by Country (2026-2031) & (K Doses)
Table 43. Latin America Ropivacaine Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Ropivacaine Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Ropivacaine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Ropivacaine Sales by Country (2020-2025) & (K Doses)
Table 47. Middle East and Africa Ropivacaine Sales by Country (2026-2031) & (K Doses)
Table 48. Middle East and Africa Ropivacaine Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Ropivacaine Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Ropivacaine Sales (K Doses) by Type (2020-2025)
Table 51. Global Ropivacaine Sales (K Doses) by Type (2026-2031)
Table 52. Global Ropivacaine Sales Market Share by Type (2020-2025)
Table 53. Global Ropivacaine Sales Market Share by Type (2026-2031)
Table 54. Global Ropivacaine Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Ropivacaine Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Ropivacaine Revenue Market Share by Type (2020-2025)
Table 57. Global Ropivacaine Revenue Market Share by Type (2026-2031)
Table 58. Global Ropivacaine Price (US$/Dose) by Type (2020-2025)
Table 59. Global Ropivacaine Price (US$/Dose) by Type (2026-2031)
Table 60. Global Ropivacaine Sales (K Doses) by Application (2020-2025)
Table 61. Global Ropivacaine Sales (K Doses) by Application (2026-2031)
Table 62. Global Ropivacaine Sales Market Share by Application (2020-2025)
Table 63. Global Ropivacaine Sales Market Share by Application (2026-2031)
Table 64. Global Ropivacaine Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Ropivacaine Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Ropivacaine Revenue Market Share by Application (2020-2025)
Table 67. Global Ropivacaine Revenue Market Share by Application (2026-2031)
Table 68. Global Ropivacaine Price (US$/Dose) by Application (2020-2025)
Table 69. Global Ropivacaine Price (US$/Dose) by Application (2026-2031)
Table 70. AstraZeneca Company Information
Table 71. AstraZeneca Description and Business Overview
Table 72. AstraZeneca Ropivacaine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 73. AstraZeneca Ropivacaine Product
Table 74. AstraZeneca Recent Developments/Updates
Table 75. Aspen Pharmacare Company Information
Table 76. Aspen Pharmacare Description and Business Overview
Table 77. Aspen Pharmacare Ropivacaine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 78. Aspen Pharmacare Ropivacaine Product
Table 79. Aspen Pharmacare Recent Developments/Updates
Table 80. Celgene Company Information
Table 81. Celgene Description and Business Overview
Table 82. Celgene Ropivacaine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 83. Celgene Ropivacaine Product
Table 84. Celgene Recent Developments/Updates
Table 85. Taiwan Liposome Company Company Information
Table 86. Taiwan Liposome Company Description and Business Overview
Table 87. Taiwan Liposome Company Ropivacaine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 88. Taiwan Liposome Company Ropivacaine Product
Table 89. Taiwan Liposome Company Recent Developments/Updates
Table 90. Nuvo Pharmaceuticals Company Information
Table 91. Nuvo Pharmaceuticals Description and Business Overview
Table 92. Nuvo Pharmaceuticals Ropivacaine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 93. Nuvo Pharmaceuticals Ropivacaine Product
Table 94. Nuvo Pharmaceuticals Recent Developments/Updates
Table 95. Heron Therapeutics Company Information
Table 96. Heron Therapeutics Description and Business Overview
Table 97. Heron Therapeutics Ropivacaine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 98. Heron Therapeutics Ropivacaine Product
Table 99. Heron Therapeutics Recent Developments/Updates
Table 100. Encore Therapeutics Company Information
Table 101. Encore Therapeutics Description and Business Overview
Table 102. Encore Therapeutics Ropivacaine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 103. Encore Therapeutics Ropivacaine Product
Table 104. Encore Therapeutics Recent Developments/Updates
Table 105. PainReform Ltd Company Information
Table 106. PainReform Ltd Description and Business Overview
Table 107. PainReform Ltd Ropivacaine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 108. PainReform Ltd Ropivacaine Product
Table 109. PainReform Ltd Recent Developments/Updates
Table 110. Anhui Wellman Pharmaceutical Company Information
Table 111. Anhui Wellman Pharmaceutical Description and Business Overview
Table 112. Anhui Wellman Pharmaceutical Ropivacaine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 113. Anhui Wellman Pharmaceutical Ropivacaine Product
Table 114. Anhui Wellman Pharmaceutical Recent Developments/Updates
Table 115. Yichang Renfu Pharmaceutical Company Information
Table 116. Yichang Renfu Pharmaceutical Description and Business Overview
Table 117. Yichang Renfu Pharmaceutical Ropivacaine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 118. Yichang Renfu Pharmaceutical Ropivacaine Product
Table 119. Yichang Renfu Pharmaceutical Recent Developments/Updates
Table 120. Shandong New Era Pharmaceutical Company Information
Table 121. Shandong New Era Pharmaceutical Description and Business Overview
Table 122. Shandong New Era Pharmaceutical Ropivacaine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 123. Shandong New Era Pharmaceutical Ropivacaine Product
Table 124. Shandong New Era Pharmaceutical Recent Developments/Updates
Table 125. Shanxi Pude Pharmaceutical Company Information
Table 126. Shanxi Pude Pharmaceutical Description and Business Overview
Table 127. Shanxi Pude Pharmaceutical Ropivacaine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 128. Shanxi Pude Pharmaceutical Ropivacaine Product
Table 129. Shanxi Pude Pharmaceutical Recent Developments/Updates
Table 130. Guangdong Huarun Shunfeng Pharmaceutical Company Information
Table 131. Guangdong Huarun Shunfeng Pharmaceutical Description and Business Overview
Table 132. Guangdong Huarun Shunfeng Pharmaceutical Ropivacaine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 133. Guangdong Huarun Shunfeng Pharmaceutical Ropivacaine Product
Table 134. Guangdong Huarun Shunfeng Pharmaceutical Recent Developments/Updates
Table 135. Guangdong Jiabo Pharmaceutical Company Information
Table 136. Guangdong Jiabo Pharmaceutical Description and Business Overview
Table 137. Guangdong Jiabo Pharmaceutical Ropivacaine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 138. Guangdong Jiabo Pharmaceutical Ropivacaine Product
Table 139. Guangdong Jiabo Pharmaceutical Recent Developments/Updates
Table 140. Chengdu Tiantaishan Pharmaceutical Company Information
Table 141. Chengdu Tiantaishan Pharmaceutical Description and Business Overview
Table 142. Chengdu Tiantaishan Pharmaceutical Ropivacaine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 143. Chengdu Tiantaishan Pharmaceutical Ropivacaine Product
Table 144. Chengdu Tiantaishan Pharmaceutical Recent Developments/Updates
Table 145. Yangtze Pharmaceutical Group Company Information
Table 146. Yangtze Pharmaceutical Group Description and Business Overview
Table 147. Yangtze Pharmaceutical Group Ropivacaine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 148. Yangtze Pharmaceutical Group Ropivacaine Product
Table 149. Yangtze Pharmaceutical Group Recent Developments/Updates
Table 150. Jiangsu Hengrui Pharmaceutical Company Information
Table 151. Jiangsu Hengrui Pharmaceutical Description and Business Overview
Table 152. Jiangsu Hengrui Pharmaceutical Ropivacaine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 153. Jiangsu Hengrui Pharmaceutical Ropivacaine Product
Table 154. Jiangsu Hengrui Pharmaceutical Recent Developments/Updates
Table 155. Jiangsu Enhua Pharmaceutical Company Information
Table 156. Jiangsu Enhua Pharmaceutical Description and Business Overview
Table 157. Jiangsu Enhua Pharmaceutical Ropivacaine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 158. Jiangsu Enhua Pharmaceutical Ropivacaine Product
Table 159. Jiangsu Enhua Pharmaceutical Recent Developments/Updates
Table 160. Hebei Yipin Pharmaceutical Company Information
Table 161. Hebei Yipin Pharmaceutical Description and Business Overview
Table 162. Hebei Yipin Pharmaceutical Ropivacaine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 163. Hebei Yipin Pharmaceutical Ropivacaine Product
Table 164. Hebei Yipin Pharmaceutical Recent Developments/Updates
Table 165. Zhejiang Xianju Pharmaceutical Company Information
Table 166. Zhejiang Xianju Pharmaceutical Description and Business Overview
Table 167. Zhejiang Xianju Pharmaceutical Ropivacaine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 168. Zhejiang Xianju Pharmaceutical Ropivacaine Product
Table 169. Zhejiang Xianju Pharmaceutical Recent Developments/Updates
Table 170. Hainan Sida Pharmaceutical Company Information
Table 171. Hainan Sida Pharmaceutical Description and Business Overview
Table 172. Hainan Sida Pharmaceutical Ropivacaine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 173. Hainan Sida Pharmaceutical Ropivacaine Product
Table 174. Hainan Sida Pharmaceutical Recent Developments/Updates
Table 175. Xi'an Hanfeng Pharmaceutical Company Information
Table 176. Xi'an Hanfeng Pharmaceutical Description and Business Overview
Table 177. Xi'an Hanfeng Pharmaceutical Ropivacaine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 178. Xi'an Hanfeng Pharmaceutical Ropivacaine Product
Table 179. Xi'an Hanfeng Pharmaceutical Recent Developments/Updates
Table 180. Chenxin Pharmaceutical Company Information
Table 181. Chenxin Pharmaceutical Description and Business Overview
Table 182. Chenxin Pharmaceutical Ropivacaine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 183. Chenxin Pharmaceutical Ropivacaine Product
Table 184. Chenxin Pharmaceutical Recent Developments/Updates
Table 185. Shaanxi Bosen Biopharmaceutical Company Information
Table 186. Shaanxi Bosen Biopharmaceutical Description and Business Overview
Table 187. Shaanxi Bosen Biopharmaceutical Ropivacaine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 188. Shaanxi Bosen Biopharmaceutical Ropivacaine Product
Table 189. Shaanxi Bosen Biopharmaceutical Recent Developments/Updates
Table 190. Qilu Pharmaceutical Company Information
Table 191. Qilu Pharmaceutical Description and Business Overview
Table 192. Qilu Pharmaceutical Ropivacaine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 193. Qilu Pharmaceutical Ropivacaine Product
Table 194. Qilu Pharmaceutical Recent Developments/Updates
Table 195. Shenyang Sansheng Pharmaceutical Company Information
Table 196. Shenyang Sansheng Pharmaceutical Description and Business Overview
Table 197. Shenyang Sansheng Pharmaceutical Ropivacaine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
Table 198. Shenyang Sansheng Pharmaceutical Ropivacaine Product
Table 199. Shenyang Sansheng Pharmaceutical Recent Developments/Updates
Table 200. Key Raw Materials Lists
Table 201. Raw Materials Key Suppliers Lists
Table 202. Ropivacaine Distributors List
Table 203. Ropivacaine Customers List
Table 204. Ropivacaine Market Trends
Table 205. Ropivacaine Market Drivers
Table 206. Ropivacaine Market Challenges
Table 207. Ropivacaine Market Restraints
Table 208. Research Programs/Design for This Report
Table 209. Key Data Information from Secondary Sources
Table 210. Key Data Information from Primary Sources
Table 211. Authors List of This Report
List of Figures
Figure 1. Product Picture of Ropivacaine
Figure 2. Global Ropivacaine Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Ropivacaine Market Share by Type: 2024 & 2031
Figure 4. Lumbar Epidural Administration Product Picture
Figure 5. Thoracic Epidural Administration Product Picture
Figure 6. Regional Block Product Picture
Figure 7. Global Ropivacaine Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Ropivacaine Market Share by Application: 2024 & 2031
Figure 9. Anesthesia
Figure 10. Systemic Neuropathic Pain
Figure 11. Postherpes Pain
Figure 12. Post-Operative Pain
Figure 13. Surgical Analgesia
Figure 14. Labor Analgesia
Figure 15. Other
Figure 16. Global Ropivacaine Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Ropivacaine Market Size (2020-2031) & (US$ Million)
Figure 18. Global Ropivacaine Sales (2020-2031) & (K Doses)
Figure 19. Global Ropivacaine Average Price (US$/Dose) & (2020-2031)
Figure 20. Ropivacaine Report Years Considered
Figure 21. Ropivacaine Sales Share by Manufacturers in 2024
Figure 22. Global Ropivacaine Revenue Share by Manufacturers in 2024
Figure 23. Global 5 and 10 Largest Ropivacaine Players: Market Share by Revenue in Ropivacaine in 2024
Figure 24. Ropivacaine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Global Ropivacaine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 26. North America Ropivacaine Sales Market Share by Country (2020-2031)
Figure 27. North America Ropivacaine Revenue Market Share by Country (2020-2031)
Figure 28. U.S. Ropivacaine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Canada Ropivacaine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Europe Ropivacaine Sales Market Share by Country (2020-2031)
Figure 31. Europe Ropivacaine Revenue Market Share by Country (2020-2031)
Figure 32. Germany Ropivacaine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. France Ropivacaine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. U.K. Ropivacaine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Italy Ropivacaine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Russia Ropivacaine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Asia Pacific Ropivacaine Sales Market Share by Region (2020-2031)
Figure 38. Asia Pacific Ropivacaine Revenue Market Share by Region (2020-2031)
Figure 39. China Ropivacaine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Japan Ropivacaine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. South Korea Ropivacaine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. India Ropivacaine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Australia Ropivacaine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Taiwan Ropivacaine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Indonesia Ropivacaine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Thailand Ropivacaine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Malaysia Ropivacaine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Philippines Ropivacaine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Latin America Ropivacaine Sales Market Share by Country (2020-2031)
Figure 50. Latin America Ropivacaine Revenue Market Share by Country (2020-2031)
Figure 51. Mexico Ropivacaine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Brazil Ropivacaine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Argentina Ropivacaine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Middle East and Africa Ropivacaine Sales Market Share by Country (2020-2031)
Figure 55. Middle East and Africa Ropivacaine Revenue Market Share by Country (2020-2031)
Figure 56. Turkey Ropivacaine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 57. Saudi Arabia Ropivacaine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 58. UAE Ropivacaine Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 59. Global Sales Market Share of Ropivacaine by Type (2020-2031)
Figure 60. Global Revenue Market Share of Ropivacaine by Type (2020-2031)
Figure 61. Global Ropivacaine Price (US$/Dose) by Type (2020-2031)
Figure 62. Global Sales Market Share of Ropivacaine by Application (2020-2031)
Figure 63. Global Revenue Market Share of Ropivacaine by Application (2020-2031)
Figure 64. Global Ropivacaine Price (US$/Dose) by Application (2020-2031)
Figure 65. Ropivacaine Value Chain
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
